Overview
Zhi-hong Chen practices in Guangzhou, China. Chen is highly rated in 6 conditions, according to our data. Their top areas of expertise are Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE), EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Cancer.
Their clinical research consists of co-authoring 96 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)
- Advanced
- EGFR Positive Lung Cancer
- Genetic Epilepsy with Febrile Seizures Plus (GEFS+)
- Lung AdenocarcinomaChen isAdvanced. Learn about Lung Adenocarcinoma.
- Lung CancerChen isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Absence SeizureChen isExperienced. Learn about Absence Seizure.
- Bone TumorChen isExperienced. Learn about Bone Tumor.
- Corpus Callosum AgenesisChen isExperienced. Learn about Corpus Callosum Agenesis.
- EpilepsyChen isExperienced. Learn about Epilepsy.
- Generalized Tonic-Clonic Seizure
- Inflammatory Myofibroblastic Tumor